128 filings
Page 2 of 7
8-K
z4m4 1l2i1f
22 Jan 24
Entry into a Material Definitive Agreement
6:12am
8-K
rr5yi 2ho
11 Jan 24
Entry into a Material Definitive Agreement
7:50pm
8-K
lcdc z2x3z1peomln
8 Jan 24
Entry into a Material Definitive Agreement
5:19pm
8-K
8sr2celjk6yc6s6siv
28 Dec 23
Other Events
4:14pm
8-K
rin7j6e
27 Dec 23
NKGen Biotech Announces Clearance of Clinical Trial Application by Health Canada for SNK01 NK Cell Therapy to Treat Alzheimer’s Disease
4:02pm
8-K
mv7 6aa5k6tlj
27 Dec 23
Entry into a Material Definitive Agreement
4:01pm
8-K
lbt 3dd185dytu
14 Nov 23
NKGen Biotech, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights
4:36pm
8-K
hkx6u6gt
30 Oct 23
Regulation FD Disclosure
8:05am
8-K
9z6mufx4eczd61spfyz7
24 Oct 23
Other Events
8:05am
8-K/A
xwzj17hfao yc
19 Oct 23
Financial Statements and Exhibits
5:23pm
8-K
35l7rl
5 Oct 23
Index to Financial Statements
5:12pm
8-K
yv2izp 41flwq3j
29 Sep 23
Entry into a Material Definitive Agreement
5:24pm
25
876r8pi
29 Sep 23
Voluntary exchange delisting
4:29pm
CERT
mckusrgb
29 Sep 23
Certification of approval for exchange listing
4:16pm
8-K
c7g0n85xrm8uyn904
29 Sep 23
Submission of Matters to a Vote of Security Holders
3:11pm
8-A12B
nwavrqej6 taf7
29 Sep 23
Registration of securities on exchange
12:03pm